Induction of a cellular and humoral immune response against preprocalcitonin by genetic immunization: A potential new treatment for medullary thyroid carcinoma

Endocrinology

Volumn 142, Issue 3, 2001, Pages 1017-1023

  Haupt, K ^b   Siegel, F ^c   Lu, M ^c   Yang, D ^c   Hilken, G ^b   Mann, K ^a   Roggendorf, M ^c   Saller, B ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HORMONE PRECURSOR; PREPROCALCITONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GENE TARGETING; GENE THERAPY; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYROID MEDULLARY CARCINOMA;

EID: 0035098031     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.3.8014     Document Type: Article

References (48)

1. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours
2. Current diagnosis and management of medullary thyroid carcinoma
3. Medullary thyroid carcinoma
4. Interleukin-2 and interleukin-4 display potent antitumour activity on rat medullary thyroid carcinoma cells
5. Immune response against medullary thyroid carcinoma (MTC) induced by parental and/or interleukin-2-secreting MTC cells in a rat model of human familial medullary thyroid carcinoma
6. Effective genetic therapy of established medullary thyroid carcinomas with murine interleukin-2: Dissemination and cytotoxicity studies in a rat tumor model
7. Treatment of medullary thyroid carcinoma by combined expression of suicide and interleukin-2 genes
8. Hammerhead ribozyme-mediated inactivation of mutant RET in medullary thyroid carcinoma
9. Cell-specific induction of sensitivity to ganciclovir in medullary thyroid carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase
10. Vaccination against human cancers
11. Structure and expression of the human calcitonin/CGRP genes
12. Model for tissue specific calcitonin/CGRP-I RNA processing from in vitro experiments
13. Genetic vaccines
14. Direct gene transfer into mouse muscle in vivo
15. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle
16. DNA vaccines-designer vaccines for the 21st century
17. DNA vaccination against multiple myeloma
18. Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes
19. Genetic immunization with the free human chorionic gonadotropin beta sub-unit elicits cytotoxic T lymphocyte responses and protects against tumor formation in mice
20. Molecular and immunological analysis of genetic prostate specific antigen (PSA) vaccine
21. Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection
22. Tumor immunity and autoimmunity induced by immumization with homologous DNA
23. Expression and function of the human calcitonin/α-CGRP gene in health and disease
24. Vaccination against hepatitis delta virus infection, studies in the woodchuck (Marmota momax) model
25. Role of procalcitonin and granulocyte colony stimulating factor in the early predicition of infected necrosis in severe acute pancreatitis
26. Molecular cloning and expression of mouse calcitonin
27. Intradermal DNA immunization of mice against influenza A virus using the novel PowderJect system
28. In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment
29. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment
30. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles
31. DNA-based immunization by in vivo transfection of dendritic cells
32. Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime
33. DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations
34. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery
35. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization
36. DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors
37. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2
38. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes
39. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids
40. Immunological memory after somatic transgene immunization is positively affected by priming with GM-CSF and does not require bone marrow-derived dendritic cells
41. Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immume responses to the middle but not to the large hepatitis B virus surface antigen in mice
42. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells
43. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells/human lung and lung cancers
44. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function
45. + T cells from αβ TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ-dependent
46. + T cell responses in antitumor immunity
47. The central role of CD4(+) T cells in the antitumor immune response
48. Induction of tumor antigen-specific immunity using plasmid DNA immunization in mice